This is an oral medication in tablet form.
Mavenclad® is a chemotherapy agent that targets certain types of white blood cells (lymphocytes) that drive the immune attack in MS. It temporarily reduces the number of both T and B lymphocytes without continuous suppression of the immune system.
Mavenclad® is approved by the FDA for adults with relapsing forms of MS, including relapsing-remitting MS and active secondary progressive MS.
to read the Prescribing Information for healthcare providers.
to read the Medication Guide for patients.
Financial Assistance ProgramMS LifeLines®